About cteph
CTEPH is rare, serious, and often overlooked. Understanding what it is and how it presents can be life saving.
what is cteph
Chronic Thromboembolic Pulmonary Hypertension, commonly known as CTEPH, is a rare but serious form of pulmonary hypertension caused by chronic blood clots in the lungs. These clots obstruct normal blood flow and place increasing pressure on the heart, particularly the right side, which must work harder to pump blood through the lungs.
Unlike acute pulmonary embolisms, which may resolve with treatment, the clots associated with CTEPH do not fully dissolve. Over time, they become organized and scar-like, permanently narrowing or blocking the pulmonary arteries.
CTEPH is considered one of the few potentially treatable forms of pulmonary hypertension, but only when it is recognized and diagnosed early.
Why CTEPH Is Often Missed
CTEPH is frequently underdiagnosed because its symptoms can appear gradually and closely resemble other common conditions. Many individuals are initially told they have asthma, anxiety, deconditioning, or general fatigue.
Common symptoms include shortness of breath during everyday activities, persistent fatigue, chest discomfort, dizziness, and swelling in the legs or ankles. Because these symptoms may develop months or even years after a blood clot event, the connection to CTEPH is often overlooked.
Without proper screening and follow up, diagnosis is delayed, and the condition continues to progress.
The Impact on the Body
As pressure builds in the pulmonary arteries, the heart is forced to work harder to circulate blood. Over time, this strain can lead to right heart failure, reduced oxygen delivery throughout the body, and severe limitations in daily life.
CTEPH does not only affect physical health. It impacts emotional well being, independence, and quality of life for both individuals and their families.
why Awareness Matters
Early detection of CTEPH can be life changing. With proper evaluation, including specialized imaging and referral to experienced centers, individuals may have access to treatments that significantly improve outcomes.
Awareness empowers patients to ask informed questions and encourages healthcare providers to consider CTEPH when symptoms persist after blood clots or pulmonary embolisms.
Too many lives are affected simply because the condition is not recognized in time.
Our Commitment to Education and Advocacy
The Tracey Anika Memorial Initiative is committed to increasing awareness of CTEPH through education, advocacy, and community engagement. By sharing information in clear and accessible language, we aim to help individuals and families recognize symptoms earlier and seek appropriate care.
Education saves lives. Awareness creates change. Advocacy honors those we have lost.
If you or someone you love is experiencing unexplained shortness of breath or lingering symptoms after a blood clot, learning more about CTEPH may be an important first step.
The information provided on this site is intended for educational and awareness purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Individuals experiencing symptoms or health concerns should seek guidance from a qualified healthcare provider.